本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Prelude Therapeutics Inc

0.7550
+0.01502.03%
成交量:6.68萬
成交額:4.98萬
市值:4,155.16萬
市盈率:-0.43
高:0.7680
開:0.7456
低:0.7020
收:0.7400
資料載入中...

公司資料

公司名字:
Prelude Therapeutics Inc
交易所:
NASDAQ
成立時間:
2016
員工人數:
128
公司地址:
175 Innovation Boulevard,Wilmington,Delaware,United States
郵編:
19805
電話:
傳真:
- -
簡介:
Prelude Therapeutics Incorporated於2016年2月5日在特拉華州成立,是一家臨床階段的精密腫瘤學公司,致力於發現和開發針對高度未滿足需求的癌症的關鍵驅動機制進行優化的小分子療法。

董事

名稱
職位
Kris Vaddi
Chief Executive Officer and Director
Paul A. Friedman
Chairman of the Board, Director
David Bonita
Director
Kelvin Neu
Director
Mardi C. Dier
Director
Victor Sandor
Director

股東

名稱
職位
Kris Vaddi
Chief Executive Officer and Director
Brian Piper
Chief Financial Officer
Andrew P. Combs
Executive Vice President and Head of Chemistry
Christopher Pierce
Executive Vice President and Chief of Business Operations
David Mauro
Chief Medical Officer
Deborah Morosini
Executive Vice President and Chief of Clinical Affairs
Peggy A. Scherle
Chief Scientific Officer